Margaret S. Pepe
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
Statistics, Medicine and Surgery, Biostatistics BiologyGoogle:
"Margaret Pepe"Children
Sign in to add trainee| Todd A. Alonzo | grad student | 2000 | University of Washington |
| Lori E. Dodd | grad student | 2001 | University of Washington |
| Chaya S. Moskowitz | grad student | 2002 | University of Washington |
| Holly Janes | grad student | 2005 | University of Washington |
| Wen Gu | grad student | 2009 | University of Washington |
| Yuying Jin | grad student | 2009 | University of Washington |
| Aasthaa Bansal | grad student | 2011 | University of Washington |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Marsh TL, Janes H, Pepe MS. (2019) Statistical inference for net benefit measures in biomarker validation studies. Biometrics |
| Elmore JG, Barnhill RL, Elder DE, et al. (2017) Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. Bmj (Clinical Research Ed.). 357: j2813 |
| Garrison CB, Marsh T, Buas M, et al. (2017) Abstract 713: Proteomic early detection biomarkers for ER+ breast cancer to improve mammography screening Cancer Research. 77: 713-713 |
| Pepe MS, Janes H, Li CI, et al. (2016) Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility? Clinical Chemistry |
| Pepe MS, Fan J, Feng Z, et al. (2015) The Net Reclassification Index (NRI): a Misleading Measure of Prediction Improvement Even with Independent Test Data Sets. Statistics in Biosciences. 7: 282-295 |
| Janes H, Brown MD, Pepe MS. (2015) Designing a study to evaluate the benefit of a biomarker for selecting patient treatment. Statistics in Medicine |
| Janes H, Pepe MS, McShane LM, et al. (2015) The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment. Journal of the National Cancer Institute. 107 |
| Elmore JG, Longton GM, Carney PA, et al. (2015) Diagnostic concordance among pathologists interpreting breast biopsy specimens. Jama. 313: 1122-32 |
| Anderson KS, Pepe M, Marks J, et al. (2015) Abstract P4-02-05: A blinded multicenter phase II study of a panel of plasma biomarkers for the detection of triple negative breast cancer Cancer Research. 75 |
| Janes H, Brown MD, Huang Y, et al. (2014) An approach to evaluating and comparing biomarkers for patient treatment selection. The International Journal of Biostatistics. 10: 99-121 |